GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Immix Biopharma, Inc. - Common Stock (IMMX)

Symbol: IMMX on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$1,287,519	246,056	+58,580	+31%	$5.23	Q4 2025
30 Sep 2025	0%	+0%	$391,870	187,476	+26,361	+16%	$2.09	Q3 2025
30 Jun 2025	0%	0%	$333,550	161,115	+373	+0.23%	$2.07	Q2 2025
31 Mar 2025	0%	+0%	$270,088	160,742	+10,660		$1.68	Q1 2025
31 Dec 2024	0%	0%	$330,234	150,082	0		$2.20	Q4 2024
30 Sep 2024	0%	+0%	$223,651	150,082	+7,954	+5.6%	$1.49	Q3 2024
30 Jun 2024	0%	+0%	$281,454	142,128	+17,358	+14%	$1.98	Q2 2024
31 Mar 2024	0%	+0%	$383,105	124,770	+41,343	+50%	$3.07	Q1 2024
31 Dec 2023	0%	+0%	$577,443	83,427	+10,405	+14%	$6.92	Q4 2023
30 Sep 2023	0%	+0%	$249,805	73,022	+12,696	+21%	$3.42	Q3 2023
30 Jun 2023	0%	-0%	$162,276	60,326	-19,396	-24%	$2.69	Q2 2023
31 Mar 2023	0%	+0%	$145,094	79,722	+3,185	+4.2%	$1.82	Q1 2023
31 Dec 2022	0%	0%	$175,000	76,537	-232	-0.3%	$2.29	Q4 2022
30 Sep 2022	0%	+0%	$104,000	76,769	+3,436	+4.7%	$1.35	Q3 2022
30 Jun 2022	0%	+0%	$190,000	73,333	+73,333	NEW	$2.59	Q2 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.